2,6-Bis(2-Benzimidazolyl)Pyridine (BBP) Is a Potent and Selective Inhibitor of Small Conductance Calcium-Activated Potassium (SK) Channels

Research output: Contribution to journalJournal articleResearchpeer-review

Rafel Simó-Vicens, Sofia Hammami Bomholtz, Ulrik Svane Sørensen, Bo Hjorth Bentzen

A variety of polycyclic pyridines have been proposed as inhibitors of the small conductance calcium-activated potassium (SK) channel. To this group belongs 2,6-bis(2-benzimidazolyl)pyridine (BBP), a commercially and readily available small organic compound which has earlier been described in a broad range of chemical and biological uses. Here, we show how BBP can also be used as a potent and specific SK channel blocker in vitro. The potency of BBP was measured using automatic patch clamp on all three SK channel subtypes, resulting in similar IC50 of 0.4 μM. We also assessed the selectivity of BBP on a panel of calcium-activated and voltage-activated potassium channels using two-electrode voltage clamp, automatic and manual patch clamp. BBP did not have any effect on IK, Kir2.1, Kir3.1+Kir3.4, Kv1.5, Kv4.3/KCHIP2 and Kv7.1/KCNE1 currents and was 4.8-fold and 46-fold more potent on all SK channel subtypes vs. BK and hERG channels, respectively. Moreover, we were able to identify H491 as a critical amino acid for the pharmacological effect of BBP on the SK channel. From a medicinal chemistry perspective, BBP could be used as a starting point for the design of new and improved SK inhibitors.
Original languageEnglish
Article number1409
JournalFrontiers in Pharmacology
Volume9
ISSN1663-9812
DOIs
Publication statusPublished - 3 Dec 2018

    Research areas

  • The Faculty of Health and Medical Sciences - small conductance calcium-activated potassium channels, BBP, SK channel, kca2 channel, 2,6-bis(2-benzimidazolyl)pyridine, polycyclic pyridine, blocker, inhibition, Inhibitor

Number of downloads are based on statistics from Google Scholar and www.ku.dk


No data available

ID: 209469279